Top compounds associated with response to MT-ND4L


Feature Type Standardized
Nominal ANOVA
mRNA fluvastatin CTRPv2 pan-cancer AAC -0.081 0.05
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.05
mRNA BRD-K58730230 CTRPv2 pan-cancer AAC 0.16 0.06
mRNA WZ8040 CTRPv2 pan-cancer AAC 0.083 0.06
mRNA AZD1480 CTRPv2 pan-cancer AAC -0.12 0.06
mRNA PF-184 CTRPv2 pan-cancer AAC -0.072 0.06
mRNA MG-132 CTRPv2 pan-cancer AAC -0.13 0.06
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC -0.072 0.06
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.074 0.06
mRNA Topotecan CTRPv2 pan-cancer AAC -0.067 0.07
Download CSV